|
PPIP5K2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.621400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.246800E-01 |
| Normal-vs-Stage2 |
4.535000E-01 |
| Normal-vs-Stage3 |
4.179000E-01 |
| Normal-vs-Stage4 |
5.244600E-01 |
| Stage1-vs-Stage2 |
5.917600E-01 |
| Stage1-vs-Stage3 |
5.130600E-01 |
| Stage1-vs-Stage4 |
5.077400E-01 |
| Stage2-vs-Stage3 |
9.705800E-01 |
| Stage2-vs-Stage4 |
8.243400E-01 |
| Stage3-vs-Stage4 |
8.484400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.361600E-01 |
| Normal-vs-AfricanAmerican |
5.259600E-01 |
| Normal-vs-Asian |
2.650200E-01 |
| Caucasian-vs-AfricanAmerican |
9.244600E-01 |
| Caucasian-vs-Asian |
2.195000E-01 |
| AfricanAmerican-vs-Asian |
2.795800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.801800E-01 |
| Normal-vs-Female |
6.569600E-02 |
| Male-vs-Female |
8.099600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.347600E-01 |
| Normal-vs-Extreme_Weight |
9.533600E-01 |
| Normal-vs-Obese |
2.521600E-01 |
| Normal-vs-Extreme_Obese |
5.044200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.001400E-01 |
| Normal_Weight-vs-Obese |
3.314200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.645000E-01 |
| Extreme_Weight-vs-Obese |
2.991800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.693000E-01 |
| Obese-vs-Extreme_Obese |
9.779000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.769600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.075800E-02 |
| Normal-vs-Age(61-80Yrs) |
6.905200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.728400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.291600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.295770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.544200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.444600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.083800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.486600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.578000E-01 |
| Normal-VS-Type2 PRCC |
7.567800E-01 |
| Normal-VS-KIRP CIMP |
1.910760E-01 |
| Normal-VS-Unclassified PRCC |
4.277900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.746800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.960360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.818400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.736000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.422300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.740100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.897000E-01 |
| Normal-vs-N1 |
3.013000E-01 |
| Normal-vs-N2 |
6.545600E-01 |
| N0-vs-N1 |
3.724600E-01 |
| N0-vs-N2 |
7.631600E-01 |
| N1-vs-N2 |
5.096400E-01 |
|
|
